BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38086310)

  • 1. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
    Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
    Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feature selection methodology for longitudinal cone-beam CT radiomics.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Lambin P
    Acta Oncol; 2017 Nov; 56(11):1537-1543. PubMed ID: 28826307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images.
    Sellami S; Bourbonne V; Hatt M; Tixier F; Bouzid D; Lucia F; Pradier O; Goasduff G; Visvikis D; Schick U
    Acta Oncol; 2022 Jan; 61(1):73-80. PubMed ID: 34632924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
    Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of radiomic features in patients with esophageal cancer treated with chemoradiotherapy.
    Jinnouchi H; Yamashita H; Nozawa Y; Nakamoto T; Sawayanagi S; Katano A
    J Cancer Res Ther; 2024 Jan; 20(1):243-248. PubMed ID: 38554328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
    BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
    Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
    Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data.
    Li ZM; Liu W; Chen XL; Wu WZ; Xu XE; Chu MY; Yu SX; Li EM; Huang HC; Xu LY
    Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102318. PubMed ID: 38471582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
    van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
    Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of reproducible radiomic features from on-board volumetric images: A multi-institutional phantom study.
    Adachi T; Nakamura M; Iramina H; Matsumoto K; Ishihara Y; Tachibana H; Kurokawa S; Cho S; Tanaka K; Fukumoto K; Nishiyama T; Kito S; Mizowaki T
    Med Phys; 2023 Sep; 50(9):5585-5596. PubMed ID: 36932977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
    Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
    Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
    Guo L; Liu A; Geng X; Zhao Z; Nie Y; Wang L; Liu D; Li Y; Li Y; Li D; Wang Q; Li Z; Liu X; Li M
    Thorac Cancer; 2024 Apr; 15(12):947-964. PubMed ID: 38480505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
    Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
    Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
    Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
    J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map.
    An D; Cao Q; Su N; Li W; Li Z; Liu Y; Zhang Y; Li B
    Front Oncol; 2022; 12():787489. PubMed ID: 35392222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining the radiomic features and traditional parameters of
    Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
    Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
    Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
    Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.